PT Bundamedik Tbk (ISX:BMHS) Retained Earnings: Rp293,337 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:BMHS PT Bundamedik Tbk ISX:BMHS
67 GF Score
Price Rp189.00
GF Value Rp262.99
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PT Bundamedik Tbk Retained Earnings?

PT Bundamedik Tbk ISX:BMHS 67 Retained Earnings is Rp293,337 Mil as of Jun. 2026. GuruFocus rates ISX:BMHS with a GF Score™ of 67/100 and a GF Value™ of Rp262.99 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. PT Bundamedik Tbk's retained earnings for the quarter that ended in Jun. 2026 was Rp293,337 Mil.

PT Bundamedik Tbk's quarterly retained earnings increased from Dec. 2025 (Rp311,803 Mil) to Mar. 2026 (Rp311,869 Mil) but then declined from Mar. 2026 (Rp311,869 Mil) to Jun. 2026 (Rp293,337 Mil).

PT Bundamedik Tbk's annual retained earnings increased from Dec. 2023 (Rp297,851 Mil) to Dec. 2024 (Rp304,976 Mil) and increased from Dec. 2024 (Rp304,976 Mil) to Dec. 2025 (Rp311,803 Mil).


PT Bundamedik Tbk  (ISX:BMHS) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


PT Bundamedik Tbk Retained Earnings Historical Data

* Premium members only.

The historical data trend for PT Bundamedik Tbk's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Bundamedik Tbk Retained Earnings Chart

PT Bundamedik Tbk Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial 242,067.06 303,294.79 297,850.80 304,976.40 311,803.14

PT Bundamedik Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 303,286.62 311,632.81 311,803.14 311,868.85 293,336.69
ISX:BMHS
67GF Score
PT Bundamedik Tbk ISX:BMHS
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Bundamedik Tbk Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of Rp293,337 Mil mean?
PT Bundamedik Tbk (ISX:BMHS) has a Retained Earnings of Rp293,337 Mil as of Jun. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on PT Bundamedik Tbk and its competitors.
Is PT Bundamedik Tbk's Retained Earnings too high?
PT Bundamedik Tbk's current Retained Earnings is Rp293,337 Mil. Overall, PT Bundamedik Tbk has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Bundamedik Tbk's Retained Earnings compare to HCA and THC?
PT Bundamedik Tbk's Retained Earnings of Rp293,337 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Healthcare Providers & Services company?
A good Retained Earnings depends on the Healthcare Providers & Services industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on PT Bundamedik Tbk and its competitors. PT Bundamedik Tbk's current Retained Earnings is Rp293,337 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Bundamedik Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Bundamedik Tbk (ISX:BMHS) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp262.99, compared to a current price of Rp189.00 — trading 28.1% below its estimated fair value. The current Retained Earnings is Rp293,337 Mil. PT Bundamedik Tbk's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For PT Bundamedik Tbk (ISX:BMHS), the current Retained Earnings is Rp293,337 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Bundamedik Tbk (ISX:BMHS) Overvalued in 2026?

Based on GuruFocus' analysis, PT Bundamedik Tbk stock appears to be undervalued. The current stock price of Rp189.00 is trading 28.1% below its estimated GF Value™ of Rp262.99. GuruFocus considers PT Bundamedik Tbk to be Modestly Undervalued.

Key valuation signals for ISX:BMHS:

  • Retained Earnings: Rp293,337 Mil
  • GF Value™: Rp262.99 vs. price of Rp189.00 (28.1% below fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the ISX:BMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Bundamedik Tbk Business Description

Address Jalan Teuku Cik Ditiro No.28, Menteng, Jakarta Pusat, IDN, 10350
PT Bundamedik Tbk is a healthcare service provider. The Company carries out its main business activities through private hospital activities. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.
67GF Score

Get the complete analysis for ISX:BMHS

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp189.00
Price
Rp262.99
GF Value